CDLX Investors Have Opportunity to Lead Cardlytics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Portfolio Pulse from
The Schall Law Firm has announced a class action lawsuit against Cardlytics, Inc. (NASDAQ: CDLX) for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934, and investors who purchased securities between March 14, 2024, and August 7, 2024, are encouraged to join the lawsuit by March 25, 2025.
February 28, 2025 | 7:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cardlytics, Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term. Investors are encouraged to join the lawsuit if they purchased shares during the specified period.
The announcement of a class action lawsuit for securities fraud is likely to negatively impact Cardlytics' stock price as it raises concerns about the company's legal and financial standing. The lawsuit pertains directly to the company's actions and could lead to financial penalties or settlements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100